CDK12 and malignant colon neoplasm: This research was primarily carried out in HCT116 and DLD-1 colon cancer cell lines, and while the basic functions of LEO1 and CDK12 in transcription are likely to be conserved, the effects of LEO1 mutations or CDK12 inhibition on target genes may differ in other cell types.